Summary
The effect of the new ACE-inhibitor, fosinopril, on insulin sensitivity (SI), glucose homoeostasis and lipid profile has been examined in 24 young, healthy, normotensive men. SI, fasting plasma glucose and insulin, serum total triglycerides (Tg) and lipoprotein cholesterol (C) fractions, and ACE activity were assessed after subjects had taken placebo for 1 week and after 3 further weeks either on placebo (12 subjects) or fosinopril 20 mg daily (12 subjects), administered in a doubleblind, randomized order. Measurements were made after 3 days on a standard diet (2500 kcal/d, 45% carbohydrates, 40% fat and 15% proteins) and after an over-night fast.
Compared with control values at the end of the runin placebo phase, fosinopril reduced plasma ACE activity (from 106 to 24 nmol·ml−1·min−1), Significantly increased plasma potassium and lowered upright systolic blood pressure. It also improved the k-value of the glucose disappearance rate after glucose load (from −1.70 to −1.88%·min−1) and tended to increase SI slightly although not significantly (from 10.2 to 12.0·10−4·min−1·μU−1·ml−1). Fasting plasma glucose, insulin, serum total, high-, low-, and very-low density lipoprotein cholesterol fractions and total triglycerides were unchanged following fosinopril and placebo.
The findings indicate that in healthy lean humans, ACE inhibition with fosinopril is neutral with regard to lipoprotein and carbohydrate metabolism, and that it may slightly enhance cellular glucose disposal. This calls for further evaluation in individuals at high risk of developing insulin resistance and in patients with impaired insulin sensitivity related to hypertension, obesity, decreased glucose tolerance and diabetes mellitus.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Tobey TA, Greenfield M, Kraemer F, Reaven GM (1981) Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglycerydemic man. Metabolism 30: 165–171
Stout RW (1970) Development of vascular lesions in insulin-treated animals fed a normal diet. Br Med J 3: 685–687
Nakao J, Ito H, Kanayasu T, Murota SI (1985) Stimulatory effect of insulin on aortic smooth muscle cell migration induced by 12-L-hydroxy-5,8,10,14 eicosatetraenoic acid and its modulation by extracellular glucose levels. Diabetes 34: 185–191
Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z (1985) Hyperinsulinemia. A link between hypertension, obesity and glucose intolerance. J Clin Invest 75: 809–817
Weidmann P (1989) Pathogenesis of hypertension accompanying diabetes mellitus. Contrib Nephrol 73: 73–90
Reaven GM (1988) Banting lecture 1988: Role of insulin resistance in human disease. Diabetes 37: 1595–1607
Houston MC (1989) New insights and new approaches for the treatment of essential hypertension: Selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension. Am Heart J 117: 911–951
Williams GH (1988) Converting-enzyme inhibitors in the treatment of hypertension. N Engl J Med 319: 1517–1525
Weidmann P, Trost BN, Ferrari P (1989) Treatment of the hypertensive diabetic: focus on calcium channel blockade. In: Zanchetti A, Omae T (eds) How should elderly hypertensive patients be treated? Springer, Berlin Heidelberg New York, pp 85–99
Passa P, LeBlanc H, Marre M (1987) Effects of enalapril in insulin-dependent diabetic subjects with mild to moderate uncomplicated hypertension. Diabetes Care 10: 200–204
Taguma Y, Kitamoto Y, Futaki G, Ueda H, Monma H, Ishizaki M, Takahasi H, Sekino H, Sasaki Y (1985) Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 313: 1617–1620
Björk S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M (1986) Benefical effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 293: 471–474
Rett K, Jauch KW, Wicklmayr M, Fink E, Dietze G, Mehnert H (1989) Increased insulin-responsivness by ACE-inhibition in noninsulin dependent diabetes mellitus. Adv Exp Med Biol 247: 207–213
Pollare T, Lithell H, Berne C (1989) A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 321: 868–873
Singhui SM, Duchin KL, Morrison RA, Willard DA, Everett DW, Frantz M (1988) Disposition of fosinopril sodium in healthy subjects. Br J Clin Pharmacol 25: 9–15
Nuttall FQ, Gannon MC, Wald JL, Ahmed M (1985) Plasma glucose and insulin profiles in normal subjects ingesting diets of varying carbohydrate, fat, and protein content. J Am Coll Nutr 4: 437–450
Beard JC, Bergman RN, Kenneth Ward W, Porte D Jr (1986) The insulin sensitivity index in nondiabetic man. Correlation between clamp derived and IVGTT-derived values. Diabetes 35: 362–369
Bergman RN, Prager R, Volund A, Olefsky JM (1987) Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79: 790–800
Yang YJ, Youn JH, Bergman RN (1987) Modified protocols improve insulin sensitivity estimation using the minimal model. Am J Physiol 253: E595-E602
Lipid Research Clinics Program (1974) Manual of laboratory operations. Lipid and lipoproteins analysis (publication NIH) 75–628, US Department of Health, Education of Welfare
Burstein M, Scholnik HR, Morfin R (1970) Rapid methods for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 11: 583–595
Ryan JW, Chung A, Ammons C, Carlton ML (1977) A simple radioassay for angiotensin-converting enzyme. Biochem J 167: 501–504
Ikkos D, Luft R (1957) On the intravenous glucose tolerance test. Acta Endocrinol (Copenh) 25: 312–334
Ferrière M, Lachkar H, Richard JL, Bringer J, Orsetti A, Mirouze J (1985) Captopril and insulin sensitivity. Ann Intern Med 102: 134–135
Rett K, Lotz N, Wicklmayr M, Fink E, Jauch KW, Günther B, Dietze G (1988) Verbesserte Insulinwirkung durch ACE-Hemmung beim Typ-II-Diabetiker. Dtsch Med Wochenschr 113: 243–249
Helderman JH, Elahi D, Andersen DK, Raizes GS, Tobin JD, Shocken D, Andres R (1983) Prevention of glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 32: 106–111
Leblanc H, Thote A, Billault B, Porquet D, Fisch A, Passa P (1988) Absence d'effet de l'enalapril sur le contrôle glycémique et la sensibilité périphérique à l'insuline chez 10 diabétiques insulino-dépendants traités par infusion continue sous-cutanée d'insuline. Presse Méd 17: 2277–2280
Abrams JJ, Ginsberg H, Grundy SM (1982) Metabolism of cholesterol and plasma triglicerides in nonketotic diabetes mellitus. Diabetes 31: 903–910
Taskinen MR, Kuusi T, Helve E, Nikkilä EA, Yki-Järvinen H (1988) Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes. Arteriosclerosis 8: 168–177
Schaeffer EJ, Levy RI (1985) Pathogenesis and management of lipoprotein disorders. N Engl J Med 312: 1300–1310
Rosman J, Weidmann P, Ferrari P (1990) Antihypertensive drugs and serum lipoproteins. J Drug Dev 3 [Suppl 1]: 129–139
Author information
Authors and Affiliations
Additional information
This work was supported in part by the Swiss National Science Foundation
Rights and permissions
About this article
Cite this article
Allemann, Y., Baumann, S., Jost, M. et al. Insulin sensitivity in normotensive subjects during angiotensin converting enzyme inhibition with fosinopril. Eur J Clin Pharmacol 42, 275–280 (1992). https://doi.org/10.1007/BF00266348
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00266348